✦ LIBER ✦

Increased serum myosin light chain 3 level in neuromuscular diseases

✍ Scribed by Mosaaki Konagaya; Dr. Yoko Konagaya; Hirosei Horikawa; Tetsuya Takayanagi

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 643 KB
Volume: 10
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.880100507

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased levels of serum pentraxin 3, a

Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease

✍ Ivana Hollan; Barbara Bottazzi; Ivan Cuccovillo; Øystein T. Førre; Knut Mikkelse 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 143 KB 👁 2 views

## Abstract ## Objective Pentraxin 3 (PTX3), a key component of innate immunity, is a strong marker of disease severity in coronary artery disease (CAD). The aim of this study was to compare levels of serum PTX3 in CAD patients with and without inflammatory rheumatic disease (IRD) and in healthy c

Increased serum levels of soluble fracta

Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis

✍ Mizuho Matsunawa; Takeo Isozaki; Tsuyoshi Odai; Nobuyuki Yajima; Hiroko T. Takeu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 2 views

## Abstract ## Objective To determine levels of soluble fractalkine (sFkn) in rheumatoid arthritis (RA) patients with and without rheumatoid vasculitis (RV), and to assess the relationship of sFkn levels to disease activity. ## Methods Serum was obtained from 98 RA patients (54 without vasculiti